论文部分内容阅读
在导致慢型克山病患者死亡的众多因素中、难治性心力衰竭及严重的多发多源室性早搏是慢型克山病的两大死因。不少作者报道乙胺碘呋酮用于治疗各种心律失常获得显著近期疗效。为探讨乙胺碘呋酮在慢型克山病引起的难治性心律失常的疗效、副作用及应用规律,我们
Among the many factors that led to death in patients with chronic Keshan disease, refractory heart failure and severe multiple-ventricular premature beats are the two leading causes of death in chronic Keshan disease. Many authors have reported that amiodarone is used to treat various arrhythmias with significant near-term efficacy. To investigate the efficacy, side effects and application of amiodarone in refractory arrhythmia caused by chronic Keshan disease, we